GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Takeda Pharmaceutical Co Ltd (FRA:TKDA) » Definitions » Market Cap

Takeda Pharmaceutical Co (FRA:TKDA) Market Cap : €40,581 Mil (As of Dec. 11, 2024)


View and export this data going back to 2019. Start your Free Trial

What is Takeda Pharmaceutical Co Market Cap?

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Takeda Pharmaceutical Co's share price for the quarter that ended in Sep. 2024 was €12.8. Takeda Pharmaceutical Co's Shares Outstanding (EOP) for the quarter that ended in Sep. 2024 was 3,170 Mil. Therefore, Takeda Pharmaceutical Co's market cap for the quarter that ended in Sep. 2024 was €40,581 Mil.

Takeda Pharmaceutical Co's quarterly market cap declined from Mar. 2024 (€40,481 Mil) to Jun. 2024 (€37,344 Mil) but then increased from Jun. 2024 (€37,344 Mil) to Sep. 2024 (€40,581 Mil).

Takeda Pharmaceutical Co's annual market cap increased from Mar. 2022 (€40,550 Mil) to Mar. 2023 (€46,014 Mil) but then declined from Mar. 2023 (€46,014 Mil) to Mar. 2024 (€40,481 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Takeda Pharmaceutical Co's Enterprise Value for Today is €66,565 Mil.


Takeda Pharmaceutical Co Market Cap Historical Data

The historical data trend for Takeda Pharmaceutical Co's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Takeda Pharmaceutical Co Market Cap Chart

Takeda Pharmaceutical Co Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Market Cap
Get a 7-Day Free Trial Premium Member Only Premium Member Only 43,617.42 48,464.16 40,549.73 46,014.09 40,480.59

Takeda Pharmaceutical Co Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Market Cap Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 45,497.81 39,536.41 40,480.59 37,344.22 40,580.61

Competitive Comparison of Takeda Pharmaceutical Co's Market Cap

For the Drug Manufacturers - Specialty & Generic subindustry, Takeda Pharmaceutical Co's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Takeda Pharmaceutical Co's Market Cap Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Takeda Pharmaceutical Co's Market Cap distribution charts can be found below:

* The bar in red indicates where Takeda Pharmaceutical Co's Market Cap falls into.



Takeda Pharmaceutical Co Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

Takeda Pharmaceutical Co's Market Cap for the fiscal year that ended in Mar. 2024 is calculated as

Market Cap (A: Mar. 2024 )=Share Price (A: Mar. 2024 )*Shares Outstanding (EOP) (A: Mar. 2024 )
=€12.9*3138.03
=€40,481

Takeda Pharmaceutical Co's Market Cap for the quarter that ended in Sep. 2024 is calculated as

Market Cap (Q: Sep. 2024 )=Share Price (Q: Sep. 2024 )*Shares Outstanding (EOP) (Q: Sep. 2024 )
=€12.8*3170.36
=€40,581

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Takeda Pharmaceutical Co  (FRA:TKDA) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the company’s debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.


Takeda Pharmaceutical Co Market Cap Related Terms

Thank you for viewing the detailed overview of Takeda Pharmaceutical Co's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.


Takeda Pharmaceutical Co Business Description

Address
1-1, Nihonbashi-Honcho 2-Chome, Chuo-ku, Tokyo, JPN, 103-8668
Takeda Pharmaceutical is Japan's largest pharmaceutical company, with revenue of JPY 4.3 trillion in fiscal 2023. The company's five core therapeutic areas are oncology, gastroenterology, neuroscience, rare diseases, and plasma-derived therapies, which account for more than 80% of revenue. Its geographic footprint is well diversified, with 50% derived from the US, 20% from Japan, 20% from Europe and Canada.

Takeda Pharmaceutical Co Headlines

No Headlines